Notice of Results

RNS Number : 9315M

Surgical Innovations Group PLC

24 August 2011

 



24 August 2011

Surgical Innovations Group plc

("SI" or "the Group")

Notice of Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, will announce its results for the six months ended 30 June 2011 on Wednesday 14 September 2011.

An analyst presentation will take place at 9:30 am on 14 September 2011 at the offices of Seymour Pierce Limited, 20 Old Bailey, London, EC4M 7EN. 

Enquiries:

Surgical Innovations Group plc

Graham Bowland, Chief Executive Officer                                                           Tel: [phone]

[e-mail]                                                                                  www.surginno.com

Seymour Pierce Limited

Freddy Crossley / Sarah Jacobs                                                                                 Tel: [phone]

Corporate Broking

Marianne Woods                                                                                                        www.seymourpierce.com

Media enquiries and for analyst meeting:

The Communications Portfolio

Ariane Comstive / Caolan Mahon                                                               Tel: [phone] / 2029

[e-mail]                                     Mob: [phone]

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 130 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of 45 distribution partners, Surgical Innovations branded products are sold in all major medical markets including North America, Europe, South Africa, the Middle East, South-east Asia and Australia.
OEM and IP	The Group supplies large medical device companies on an OEM basis, collecting sales fees as well as IP license and royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, such as turbines, in situ with minimum disassembly and downtime.

For more information, see www.surginno.com 

 

END

 

 

NORZMGZRDDVGMZG